Literature DB >> 8381807

Antibodies against papillomavirus antigens in cervical secretions from condyloma patients.

L Dillner1, A Fredriksson, E Persson, O Forslund, B G Hansson, J Dillner.   

Abstract

Samples of cervical secretions and serum from 30 women with genital condylomas and 30 age-matched controls were tested for the presence of immunoglobulin A (IgA) and IgG antibodies against a panel of papillomavirus-derived antigens. The same cervical samples were also analyzed for presence of human papillomavirus (HPV) DNA by Southern blotting and polymerase chain reaction. By Southern blotting HPV DNA was detected in 8 of 30 patients with condylomas and 2 of 30 controls, and by the polymerase chain reaction HPV DNA was detected in 14 of 30 patients with condylomas and 5 of 30 controls. A total of 18 of 29 patients with condylomas and 8 of 28 controls had IgA antibodies in cervical secretions to an E2 synthetic peptide, and 17 of 29 patients with condylomas and 5 of 28 controls had local IgA antibodies to an E7 peptide (P < 0.025 and P < 0.005, respectively). The results suggest that measurement of local antibody production against selected HPV antigens may be useful in the study of HPV immunology and, possibly, for the diagnosis of HPV infection.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8381807      PMCID: PMC262734          DOI: 10.1128/jcm.31.2.192-197.1993

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  27 in total

1.  Antibodies to human papillomavirus type 16 in patients with cervical neoplasia.

Authors:  W C Reeves; J A Rawls; M Green; W E Rawls
Journal:  Lancet       Date:  1990-03-03       Impact factor: 79.321

Review 2.  Heterogeneity of the human papillomavirus group.

Authors:  E M de Villiers
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

Review 3.  Human papillomaviruses and genital cancer.

Authors:  H Pfister
Journal:  Adv Cancer Res       Date:  1987       Impact factor: 6.242

4.  Human antibodies react with an epitope of the human papillomavirus type 6b L1 open reading frame which is distinct from the type-common epitope.

Authors:  S A Jenison; X P Yu; J M Valentine; D A Galloway
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

Review 5.  Genital warts, papillomaviruses, and genital malignancies.

Authors:  K V Shah; J Buscema
Journal:  Annu Rev Med       Date:  1988       Impact factor: 13.739

6.  Mapping of linear epitopes of human papillomavirus type 16: the L1 and L2 open reading frames.

Authors:  J Dillner; L Dillner; G Utter; C Eklund; A Rotola; S Costa; D DiLuca
Journal:  Int J Cancer       Date:  1990-03-15       Impact factor: 7.396

7.  A synthetic peptide defines a serologic IgA response to a human papillomavirus-encoded nuclear antigen expressed in virus-carrying cervical neoplasia.

Authors:  J Dillner; L Dillner; J Robb; J Willems; I Jones; W Lancaster; R Smith; R Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

8.  Cloning and characterization of the DNA of a new human papillomavirus from a woman with dysplasia of the uterine cervix.

Authors:  A T Lorincz; W D Lancaster; G F Temple
Journal:  J Virol       Date:  1986-04       Impact factor: 5.103

9.  Detection of IgA antibodies against human papillomavirus in cervical secretions from patients with cervical intraepithelial neoplasia.

Authors:  L Dillner; Z Bekassy; N Jonsson; J Moreno-Lopez; J Blomberg
Journal:  Int J Cancer       Date:  1989-01-15       Impact factor: 7.396

10.  Antibodies against the human papillomavirus type 16 early proteins in human sera: correlation of anti-E7 reactivity with cervical cancer.

Authors:  I Jochmus-Kudielka; A Schneider; R Braun; R Kimmig; U Koldovsky; K E Schneweis; K Seedorf; L Gissmann
Journal:  J Natl Cancer Inst       Date:  1989-11-15       Impact factor: 13.506

View more
  4 in total

1.  Cervical mucus antibodies against human papillomavirus type 16, 18, and 33 capsids in relation to presence of viral DNA.

Authors:  Z Wang; B G Hansson; O Forslund; L Dillner; M Sapp; J T Schiller; B Bjerre; J Dillner
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

2.  Analysis of human immunoglobulin-degrading cysteine proteinases of Trichomonas vaginalis.

Authors:  D Provenzano; J F Alderete
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

Review 3.  Immunomanipulative strategies for the control of human papillomavirus associated cervical disease.

Authors:  R W Tindle
Journal:  Immunol Res       Date:  1997       Impact factor: 4.505

Review 4.  Infection and vaccine-induced HPV-specific antibodies in cervicovaginal secretions. A review of the literature.

Authors:  Jade Pattyn; Severien Van Keer; Wiebren Tjalma; Veerle Matheeussen; Pierre Van Damme; Alex Vorsters
Journal:  Papillomavirus Res       Date:  2019-09-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.